News | ECG | January 08, 2019

EKG With Artificial Intelligence Reliably Detects Heart Failure Precursor

Pairing electrocardiogram with AI offers widely available, inexpensive way to detect asymptomatic left ventricular dysfunction

EKG With Artificial Intelligence Reliably Detects Heart Failure Precursor

January 8, 2019 — A Mayo Clinic study finds that applying artificial intelligence (AI) to a widely available, inexpensive electrocardiogram (EKG) results in a simple, affordable early indicator of asymptomatic left ventricular dysfunction, a precursor to heart failure. The research team found that the AI/EKG test accuracy compares favorably with other common screening tests, such as mammography for breast cancer. The findings were published in Nature Medicine.1

Asymptomatic left ventricular dysfunction is characterized by the presence of a weak heart pump with a risk of overt heart failure. It affects 7 million Americans, and is associated with reduced quality of life and longevity. But asymptomatic left ventricular dysfunction is treatable when identified.

However, there is no inexpensive, noninvasive, painless screening tool for asymptomatic left ventricular dysfunction available for diagnostic use. The Mayo study reports that the best existing screening test for asymptomatic left ventricular dysfunction is to measure natriuretic peptide levels (BNP). Results of BNP have been disappointing, however, and the test requires blood draws. Left ventricular dysfunction typically is diagnosed with expensive and less accessible imaging tests, such as echocardiograms, or computed tomography (CT) or magnetic resonance imaging (MRI) scans.

“Congestive heart failure afflicts more than 5 million people and consumes more than $30 billion in health care expenditures in the U.S. alone,” said Paul Friedman, M.D., senior author and chair of the Midwest Department of Cardiovascular Medicine at Mayo Clinic. "The ability to acquire an ubiquitous, easily accessible, inexpensive recording in 10 seconds – the EKG – and to digitally process it with AI to extract new information about previously hidden heart disease holds great promise for saving lives and improving health," he said.

In their study, Mayo Clinic researchers hypothesized that asymptomatic left ventricular dysfunction could be reliably detected in the EKG by a properly trained neural network. Using Mayo Clinic stored digital data, 625,326 paired EKG and transthoracic echocardiograms were screened to identify the population to be studied for analysis. To test their hypothesis, researchers created, trained, validated and then tested a neural network.

The study concluded that AI applied to a standard EKG reliably detects asymptomatic left ventricular dysfunction. The accuracy of the AI/EKG test compares favorably with other common screening tests, such as prostate-specific antigen for prostate cancer, mammography for breast cancer and cervical cytology for cervical cancer.

In addition, in patients without ventricular dysfunction, those with a positive AI screen were at four times the risk of developing future ventricular dysfunction, compared with those with a negative screen. “In other words, the test not only identified asymptomatic disease, but also predicted risk of future disease, presumably by identifying very early, subtle EKG changes that occur before heart muscle weakness,” noted Friedman.

For more information: www.nature.com/nm

Reference

1. Attia Z.I., Kapa S., Lopez-Jimenez F., et al. Screening for cardiac contractile dysfunction using an artificial intelligence–enabled electrocardiogram. Nature Medicine, Jan. 7, 2019. https://doi.org/10.1038/s41591-018-0240-2


Related Content

News | Artificial Intelligence

June 17, 2024 — aycan, a recognized leader in medical imaging, announced today a reseller and technology partnership ...

Home June 17, 2024
Home
News | Artificial Intelligence

June 11, 2024 — Using an advanced artificial intelligence tool, researchers at the Icahn School of Medicine at Mount ...

Home June 11, 2024
Home
News | Artificial Intelligence

June 5, 2024 — UltraSight, a pioneer in digital health transforming cardiac imaging with artificial intelligence, is ...

Home June 05, 2024
Home
News | Artificial Intelligence

June 4, 2024 — Caristo Diagnostics Limited, a global provider of cardiovascular disease diagnostics and risk prediction ...

Home June 04, 2024
Home
News | Artificial Intelligence

May 31, 2024 — InfoBionic.ai and HBox.ai announced a groundbreaking partnership that brings together the leading AI ...

Home May 31, 2024
Home
Videos | Artificial Intelligence

In DAIC's continuing Thought Leadership Series with Dr. Jeffrey Soble, a practicing cardiologist at Rush University ...

Home May 30, 2024
Home
News | Artificial Intelligence

May 24, 2024 — An artificial intelligence (AI) program developed by investigators in the Smidt Heart Institute and their ...

Home May 24, 2024
Home
News | Artificial Intelligence

May 21, 2024 — Anumana, a Cambridge, MA-based artificial intelligence (AI)-driven health technology company and ...

Home May 21, 2024
Home
News | Artificial Intelligence

May 2, 2024 — Artificial intelligence experts at Cedars-Sinai and the Smidt Heart Institute created a dataset with more ...

Home May 02, 2024
Home
News | Artificial Intelligence

May 1, 2024 — In an ischemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer ...

Home May 01, 2024
Home
Subscribe Now